Results
The incidence of the primary end point was:
- 9.6% in the angioplasty group
- 13.7% in the t-PA group
- odds ratio= 0.67 (95 percent confidence interval, 0.47 to 0.97; P = 0.033)
Death occurred in 5.7 percent of the patients assigned to angioplasty and 7.0 percent of those assigned to t-PA (P=0.37).
Reinfarction in 4.5 percent and 6.5 percent (P=0.13).
Disabling stroke in 0.2 percent and 0.9 percent (P=0.11).
The primary end point was observed in 10.6 percent of the patients in the angioplasty group assigned to heparin and 8.2 percent of those assigned to hirudin (P=0.37).
There was no significant difference in outcome at six months.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.